Is IGO Entering FY2027 With Stronger Lithium Momentum and Financial Flexibility?
Source: Kapitales ResearchHighlights
Greenbushes delivered 387,000 tonnes of spodumene production and an 80% quarterly EBITDA margin.
Underlying free cash flow nearly doubled quarter on quarter to AU$69.5 million.
Net cash strengthened to AU$386.5 million, supporting exploration and portfolio repositioning.
Strong Quarterly Finish Lifts Investor SentimentIGO Limited (ASX: IGO) traded 3.11% higher at a CMP of AU$6.960 after reporting a resilient June 2026 quarter, supported by improved Greenbushes production, stronger spodumene pricing and increased cash generation.
The company concluded FY2026 with underlying EBITDA of AU$117.8 million for the fourth quarter, broadly stable against AU$118.9 million in the March quarter. Sales revenue advanced 18% sequentially to AU$141.4 million, mainly reflecting stronger copper sales volumes and realised pricing from the Nova operation. More importantly, underlying free cash flow increased 94% to AU$69.5 million, while net cash rose by AU$59.5 million to AU$386.5 million.
The stronger liquidity position provides IGO with greater flexibility as it simplifies its asset portfolio and redirects investment towards lithium and copper growth opportunities.Greenbushes Emerges as the Key Earnings DriverGreenbushes delivered a stronger operating quarter, with spodumene production increasing 10% to 387,000 tonnes. Sales rose 12% to 391,000 tonnes, partly because a shipment delayed from the previous quarter was recognised during the period.
The most significant improvement came from pricing. Greenbushes achieved an average realised spodumene price of US$2,286 per tonne, representing a 37% sequential increase from US$1,668 per tonne. The business reported an EBITDA margin of 80% for the June quarter, representing an increase from 75% in the March quarter.
Chemical Grade Plant 3 contributed 71,000 tonnes before a fire halted production for approximately seven weeks. Management indicated that operations were expected to restart shortly after the quarterly announcement. Although the incident presents a near-term operational risk, the plant had been ramping up ahead of schedule before production was interrupted.For FY2027, Greenbushes is targeting spodumene production of between 1.55 million and 1.75 million tonnes, with production cash costs of AU$380–AU$440 per tonne. Capital expenditure is expected to range from AU$250 million to AU$300 million.Kwinana Remains the Principal Earnings ChallengePerformance at the Kwinana lithium hydroxide refinery remained weak. Production declined 71% quarter on quarter to 897 tonnes as a major planned shutdown affected plant availability. Sales fell 70% to 864 tonnes, while conversion costs climbed to AU$40,670 per tonne due to significantly lower production volumes.
Kwinana recorded an EBITDA loss of AU$88.4 million on a 100% basis. The result included an AU$34.6 million negative net realisable value adjustment related to inventory. A further shutdown scheduled for July and August is expected to constrain September-quarter production.
IGO has guided to FY2027 lithium hydroxide production of 9,000–11,000 tonnes and conversion costs of AU$16,000–AU$18,000 per tonne. Achieving these targets will require materially improved plant reliability and operating utilisation.Nova Delivers Cash Before Planned ExitNova produced 3,882 tonnes of nickel and 1,694 tonnes of copper during the quarter. Although output declined following an April shutdown, copper sales increased 79% to 2,645 tonnes, helping quarterly revenue rise 18%.
Nova generated free cash flow of AU$78.9 million, up from AU$52.3 million in the previous quarter. However, underlying EBITDA fell 49% to AU$30.6 million, partly because of rehabilitation, retention and redundancy provisions linked to the mine’s approaching closure.
IGO has agreed to divest Nova to Global Lithium Resources after mining concludes, which is expected during the December 2026 quarter. The transaction supports management’s objective of concentrating capital on assets with longer strategic relevance.Portfolio Simplification Supports Future GrowthIGO is repositioning itself as a more focused copper and lithium business. The company is assessing options to monetise the Cosmos Project, expanding exploration activity and evaluating selective acquisitions.
Its proprietary BioHeap technology is also being adapted for copper extraction from lower-grade sulphide resources. If commercially proven, the process could potentially improve the economic viability of deposits that are difficult to develop using conventional methods.Outlook: Execution Will Determine the Next Re-RatingIGO enters FY2027 with stronger cash reserves, recovering spodumene economics, and substantial exposure to Greenbushes. These strengths are partly offset by Kwinana’s persistent losses, commissioning risk at CGP3 and the approaching end of Nova’s operating life.
The next phase of shareholder value creation will depend on Greenbushes meeting its higher production target, Kwinana demonstrating sustainable operational improvement, and management maintaining discipline while pursuing copper and lithium growth. At AU$6.960 CMP, the market’s positive reaction appears to reflect improving lithium earnings and cash generation, although execution at Kwinana remains the key variable for a more durable re-rating.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Is IGO Entering FY2027 With Stronger Lithium Momentum and Financial Flexibility?
Strong Quarterly Finish Lifts Investor SentimentIGO Limited (ASX: IGO) traded 3.11% higher at a CMP of AU$6.960 after reporting a resilient June 2026 quarter, supported by improved Greenbushes production, stronger spodumene pricing and increased cash generation.
The company concluded FY2026 with underlying EBITDA of AU$117.8 million for the fourth quarter, broadly stable against AU$118.9 million in the March quarter. Sales revenue advanced 18% sequentially to AU$141.4 million, mainly reflecting stronger copper sales volumes and realised pricing from the Nova operation. More importantly, underlying free cash flow increased 94% to AU$69.5 million, while net cash rose by AU$59.5 million to AU$386.5 million.
The stronger liquidity position provides IGO with greater flexibility as it simplifies its asset portfolio and redirects investment towards lithium and copper growth opportunities.Greenbushes Emerges as the Key Earnings DriverGreenbushes delivered a stronger operating quarter, with spodumene production increasing 10% to 387,000 tonnes. Sales rose 12% to 391,000 tonnes, partly because a shipment delayed from the previous quarter was recognised during the period.
The most significant improvement came from pricing. Greenbushes achieved an average realised spodumene price of US$2,286 per tonne, representing a 37% sequential increase from US$1,668 per tonne. The business reported an EBITDA margin of 80% for the June quarter, representing an increase from 75% in the March quarter.
Chemical Grade Plant 3 contributed 71,000 tonnes before a fire halted production for approximately seven weeks. Management indicated that operations were expected to restart shortly after the quarterly announcement. Although the incident presents a near-term operational risk, the plant had been ramping up ahead of schedule before production was interrupted.For FY2027, Greenbushes is targeting spodumene production of between 1.55 million and 1.75 million tonnes, with production cash costs of AU$380–AU$440 per tonne. Capital expenditure is expected to range from AU$250 million to AU$300 million.Kwinana Remains the Principal Earnings ChallengePerformance at the Kwinana lithium hydroxide refinery remained weak. Production declined 71% quarter on quarter to 897 tonnes as a major planned shutdown affected plant availability. Sales fell 70% to 864 tonnes, while conversion costs climbed to AU$40,670 per tonne due to significantly lower production volumes.
Kwinana recorded an EBITDA loss of AU$88.4 million on a 100% basis. The result included an AU$34.6 million negative net realisable value adjustment related to inventory. A further shutdown scheduled for July and August is expected to constrain September-quarter production.
IGO has guided to FY2027 lithium hydroxide production of 9,000–11,000 tonnes and conversion costs of AU$16,000–AU$18,000 per tonne. Achieving these targets will require materially improved plant reliability and operating utilisation.Nova Delivers Cash Before Planned ExitNova produced 3,882 tonnes of nickel and 1,694 tonnes of copper during the quarter. Although output declined following an April shutdown, copper sales increased 79% to 2,645 tonnes, helping quarterly revenue rise 18%.
Nova generated free cash flow of AU$78.9 million, up from AU$52.3 million in the previous quarter. However, underlying EBITDA fell 49% to AU$30.6 million, partly because of rehabilitation, retention and redundancy provisions linked to the mine’s approaching closure.
IGO has agreed to divest Nova to Global Lithium Resources after mining concludes, which is expected during the December 2026 quarter. The transaction supports management’s objective of concentrating capital on assets with longer strategic relevance.Portfolio Simplification Supports Future GrowthIGO is repositioning itself as a more focused copper and lithium business. The company is assessing options to monetise the Cosmos Project, expanding exploration activity and evaluating selective acquisitions.
Its proprietary BioHeap technology is also being adapted for copper extraction from lower-grade sulphide resources. If commercially proven, the process could potentially improve the economic viability of deposits that are difficult to develop using conventional methods.Outlook: Execution Will Determine the Next Re-RatingIGO enters FY2027 with stronger cash reserves, recovering spodumene economics, and substantial exposure to Greenbushes. These strengths are partly offset by Kwinana’s persistent losses, commissioning risk at CGP3 and the approaching end of Nova’s operating life.
The next phase of shareholder value creation will depend on Greenbushes meeting its higher production target, Kwinana demonstrating sustainable operational improvement, and management maintaining discipline while pursuing copper and lithium growth. At AU$6.960 CMP, the market’s positive reaction appears to reflect improving lithium earnings and cash generation, although execution at Kwinana remains the key variable for a more durable re-rating.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au